Janux Insider Sale: Noel’s Tax‑Cover Move Is Routine, Not a Signal
Janux insider sale: Noel’s tax‑cover trade shows no shift in strategy—just routine equity handling amid biotech volatility. Investors see no new risk or upside.
3 minutes to read
JANUX THERAPEUTICS INC